ORMP
Oramed Pharmaceuticals Inc
4.70$
+1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Oramed Pharmaceuticals Inc (ORMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -9.1 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.1 | -4.9 | 4.7 | -5.8 | -15 | -13 | -12 | -21 | -29 | -10 | -8.4 | -9.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | |
| 1.5 | 1.3 | 0.6 | 1.6 | 1.5 | 0.8 | 0.5 | 2.7 | 12 | 4.2 | 4.1 | 6.0 | |
| 0.2 | 0.9 | 15 | 2.9 | -3.6 | 0.3 | -3.2 | -1.3 | -0.9 | -2.7 | 3.2 | -1.9 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.4 | 0.5 | 0.3 | 0.0 | 1.9 | |
| -13 | -3.3 | -16 | 4.3 | -7.0 | 11 | 4.6 | -22 | 30 | -73 | 106 | 5.4 | |
| – | – | – | – | – | – | – | – | – | – | – | 11 | |
| – | – | – | – | – | – | – | – | – | 0.0 | -2.5 | -4.7 | |
| – | – | – | – | – | – | – | – | 0.0 | 50 | -50 | 0.0 | |
| 17 | 9.7 | 12 | 1.6 | 23 | – | 24 | 101 | 12 | 52 | -52 | -4.7 | |
| -0.5 | 1.5 | 0.7 | 0.1 | 1.0 | -1.7 | 16 | 58 | -37 | -31 | 45 | -8.5 | |
| -4.1 | -4.9 | 4.6 | -5.8 | -15 | -13 | -13 | -22 | -29 | -11 | -8.4 | -11 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.